Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Hematology · Chronic myelomonocytic leukemia

Symptoms, Autoimmune Links, and Warning Signs

At a Glance

CMML can cause fatigue, breathlessness, bruising, infections, an enlarged spleen, fevers, night sweats, and weight loss. A fever of 38.0°C (100.4°F), uncontrolled bleeding, severe left-sided abdominal pain, reduced urination, or new neurologic symptoms need urgent medical evaluation.

Living with CMML means managing a wide range of symptoms that can shift over time. Because this condition is an “overlap” of two different types of blood disorders, your symptoms may stem from having too few healthy blood cells or from having too many abnormal ones. Understanding these changes and knowing which symptoms require immediate medical attention is a vital part of your care.

Common Symptoms and Their Causes

Most CMML symptoms are related to cytopenias (low blood cell counts) or proliferative features (the overgrowth of abnormal cells).

Effects of Low Blood Counts

When your bone marrow cannot produce enough healthy blood cells, you may experience:

  • Anemia (Low Red Blood Cells): This is very common and often causes persistent fatigue, shortness of breath (dyspnea) during activity, dizziness, and a pale appearance (pallor) [1][2].
  • Thrombocytopenia (Low Platelets): Platelets help your blood clot. Low levels can lead to easy bruising, small red or purple spots on the skin (petechiae), or frequent nose and gum bleeds [3][4].
  • Neutropenia (Low White Blood Cells): Although CMML involves high monocytes, other protective white blood cells (neutrophils) may be low, making you more susceptible to frequent or lingering infections.

Effects of Overproduction (Proliferation)

If your CMML is “proliferative,” your body is making too many monocytes and other cells. This can cause:

  • Splenomegaly (Enlarged Spleen): The spleen often filters out the excess abnormal cells, causing it to grow. This may lead to a feeling of fullness or pain in the left side of your abdomen and early satiety—feeling full after eating only a small amount of food [5][6].
  • Constitutional Symptoms: The activity of the cancer can cause “whole-body” symptoms, including unexplained fevers, heavy night sweats, and unintentional weight loss [5].

The CMML and Autoimmune Connection

Research shows a strong link between CMML and autoimmune or inflammatory conditions, occurring in approximately 20% of patients [7][8]. In some cases, these inflammatory symptoms appear before the CMML is even diagnosed.

Commonly associated conditions include:

  • Systemic Vasculitis: Inflammation of the blood vessels, which can cause skin rashes, nerve pain, or organ damage. Specific types like polyarteritis nodosa (PAN) or large-vessel vasculitis have been documented in CMML patients [9][10].
  • Inflammatory Arthritis: Persistent joint pain, swelling, and stiffness [11].
  • Neutrophilic Dermatosis: Inflammatory skin conditions that may cause painful sores or plaques [12].

These conditions happen because the abnormal CMML cells can “confuse” the immune system, causing it to attack healthy tissues. Managing the CMML itself often helps improve these autoimmune symptoms [9].

Urgent “Red Flag” Symptoms

While many CMML symptoms are chronic and managed over time, some situations require emergency medical evaluation. If you experience any of the following, contact your hematology team or go to an emergency room immediately.

Infection and Bleeding (The Most Common Emergencies)

Because your marrow may not make enough healthy neutrophils or platelets, you are at risk for severe infections or uncontrolled bleeding.

  • Fever: A single temperature of 38.0°C / 100.4°F (or the threshold given by your clinic) is often treated as a medical emergency because it can indicate a life-threatening infection. Do not wait for your next scheduled appointment. Call your clinic or go to the emergency room immediately.
  • Bleeding: Uncontrolled nosebleeds, bleeding gums, black or bloody stools, or vomiting blood require immediate emergency care.

Acute Kidney Issues (Lysozyme-Induced Nephropathy)

High levels of monocytes can produce an enzyme called lysozyme. If levels get too high, this enzyme can damage the filters in your kidneys, leading to sudden kidney failure (Acute Kidney Injury) [13][14].

  • Warning Signs: A significant decrease in urine output, swelling in the legs or face, or new, extreme fatigue. This requires specific specialist management.

Leukostasis (Blood “Sludging”)

In rare cases where the white blood cell count becomes extremely high, the blood can become “thick,” making it hard for it to flow through small vessels. This is a life-threatening emergency [15].

  • Warning Signs: New or worsening shortness of breath, sudden confusion, severe headache, or changes in your vision [16][17]. While treatments like hydroxyurea or leukapheresis are sometimes used by specialists for severe hyperleukocytosis, this is uncommon and requires expert evaluation [18][19].

Splenic Complications

An extremely enlarged spleen is at risk for infarction (loss of blood supply) or, rarely, rupture [20][21].

  • Warning Signs: Sudden, severe pain in the left upper abdomen or left shoulder, often accompanied by feeling faint or lightheaded (signs of internal bleeding).

Leukemia Cutis (Skin Infiltration)

Sometimes CMML cells can travel from the blood into the skin. This can be a sign that the disease is changing or becoming more aggressive [22][23].

  • Warning Signs: New, firm, skin-colored or purple-to-red bumps or nodules on the skin that do not go away. A skin biopsy is needed to confirm if these are related to your CMML [24]. These usually require a prompt clinical assessment by your doctor, rather than an immediate trip to the emergency room.

Common questions in this guide

What symptoms are common in chronic myelomonocytic leukemia?
Common symptoms of CMML include fatigue, shortness of breath, dizziness, easy bruising, small red or purple skin spots, nose or gum bleeding, and frequent or lingering infections. Some people also develop an enlarged spleen, abdominal fullness, early fullness after eating, fevers, night sweats, or unintentional weight loss.
Can CMML cause autoimmune or inflammatory symptoms?
Yes. CMML can occur with conditions such as blood-vessel inflammation, inflammatory arthritis, and painful inflammatory skin conditions, and these symptoms may appear before CMML is diagnosed. These problems affect roughly one in five people with CMML, and treating CMML may improve the inflammation, but new joint pain, rashes, or fevers should be discussed with the care team.
What fever is an emergency for someone with CMML?
A temperature of 38.0°C (100.4°F) once, or the fever threshold your clinic gave you, should be treated as urgent because it may signal a serious infection. Call your hematology team or go to an emergency room immediately rather than waiting for your next appointment.
When does CMML-related bleeding need emergency care?
Uncontrolled nosebleeds or gum bleeding, black or bloody stools, and vomiting blood require immediate emergency evaluation. Do not wait for the bleeding to stop on its own or for a scheduled appointment.
What symptoms could signal a serious CMML complication?
A marked drop in urine, swelling of the legs or face, or new extreme fatigue can signal kidney injury. New or worsening shortness of breath, confusion, severe headache, or vision changes can occur when very high white-cell counts interfere with blood flow; these symptoms need emergency medical evaluation.
What should I do about new skin nodules with CMML?
New firm skin-colored or purple-to-red bumps that do not go away should be assessed promptly by your doctor. A skin biopsy may be needed to determine whether CMML cells have entered the skin, a finding called leukemia cutis; this usually requires prompt clinical review rather than an emergency-room visit unless other emergency symptoms are present.
When is sudden abdominal pain an emergency in CMML?
Sudden, severe pain in the upper-left abdomen or left shoulder, especially with faintness or lightheadedness, may signal a serious spleen complication such as loss of blood supply or rupture. Seek emergency care immediately because rupture can cause internal bleeding.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on chronic monocytic leukemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What are my current hemoglobin and platelet levels, and how do they compare to my last check?
  2. 2.What is the specific temperature threshold I should use to call the clinic for a fever?
  3. 3.Should I see a rheumatologist to evaluate my joint pain or unexplained fevers for a possible autoimmune connection?
  4. 4.If I develop new skin nodules, how quickly should I have them biopsied to check for leukemia cutis?
  5. 5.At what white blood cell count would you consider my condition to be 'proliferative' and needing more aggressive management?

References

References (24)
  1. 1

    Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30.

    Regnault A, Pompilus F, Ciesluk A, et al.

    Journal of patient-reported outcomes 2021; (5(1)):60 doi:10.1186/s41687-021-00334-w.

    PMID: 34283303
  2. 2

    Chronic myelomonocytic leukemia diagnosis and management.

    Chan O, Renneville A, Padron E

    Leukemia 2021; (35(6)):1552-1562 doi:10.1038/s41375-021-01207-3.

    PMID: 33714974
  3. 3

    Massive Right Atrial Thrombosis: Are You Brave Enough to Start Anticoagulation? A Case Report.

    Bergonti M, Ascione C, Agostoni P, et al.

    Frontiers in cardiovascular medicine 2021; (8()):688351 doi:10.3389/fcvm.2021.688351.

    PMID: 34395558
  4. 4

    Germline CSF3R Variant in Chronic Myelomonocytic Leukemia: Linking Genetic Predisposition to Uncommon Hemorrhagic Symptoms.

    Bochicchio MT, Micucci G, Asioli S, et al.

    International journal of molecular sciences 2023; (24(22)) doi:10.3390/ijms242216021.

    PMID: 38003211
  5. 5

    Contemporary Risk Stratification and Treatment of Chronic Myelomonocytic Leukemia.

    Tremblay D, Rippel N, Feld J, et al.

    The oncologist 2021; (26(5)):406-421 doi:10.1002/onco.13769.

    PMID: 33792103
  6. 6

    The Missing LNK: Evolution from Cytosis to Chronic Myelomonocytic Leukemia in a Patient with Multiple Sclerosis and Germline SH2B3 Mutation.

    Gundabolu K, Dave BJ, Alvares CJ, et al.

    Case reports in genetics 2022; (2022()):6977041 doi:10.1155/2022/6977041.

    PMID: 35281324
  7. 7

    Chronic Myelomonocytic Leukemia Presenting With Polyserositis and Seropositivity for Rheumatoid Arthritis.

    Kunnumpurath A, Desikan SP, McClain C, Desikan R

    Journal of investigative medicine high impact case reports 2020; (8()):2324709620966863 doi:10.1177/2324709620966863.

    PMID: 33084368
  8. 8

    Autoimmune disease in CMML-the chicken or the egg?

    Ambinder AJ, Miller J, DeZern AE

    Best practice & research. Clinical haematology 2020; (33(2)):101136 doi:10.1016/j.beha.2019.101136.

    PMID: 32460986
  9. 9

    Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: A series of 26 cases and literature review.

    Grignano E, Mekinian A, Braun T, et al.

    Leukemia research 2016; (47()):136-41.

    PMID: 27337291
  10. 10

    Polyarteritis nodosa associated with VEXAS syndrome and chronic myelomonocytic leukemia: a case-control study.

    Cioni P, Nguyen Y, Rohmer J, et al.

    Rheumatology (Oxford, England) 2026; (65(2)) doi:10.1093/rheumatology/keaf685.

    PMID: 41437650
  11. 11

    Chronic myelomonocytic leukemia mimicking hematologic systemic lupus erythematosus.

    Moura CA, Santiago M, Neto J, et al.

    Lupus 2017; (26(2)):204-207 doi:10.1177/0961203316657436.

    PMID: 27365372
  12. 12

    Impact of concurrent autoimmune conditions on clinical outcomes and leukaemic transformation in chronic myelomonocytic leukaemia.

    Rungjirajittranon T, Ponvilawan B, Sukpanichnant S, Owattanapanich W

    Journal of clinical pathology 2026; (79(5)):315-324 doi:10.1136/jcp-2025-210517.

    PMID: 41781199
  13. 13

    Clinicopathologic Spectrum of Lysozyme-Associated Nephropathy.

    Kudose S, Cossey LN, Canetta PA, et al.

    Kidney international reports 2023; (8(8)):1585-1595 doi:10.1016/j.ekir.2023.05.007.

    PMID: 37547521
  14. 14

    Severe electrolyte derangements from lysozymuria in acute myeloid leukemia.

    Pérez-Pinzón J, Olin RL, Banerjee R

    EJHaem 2022; (3(3)):1018-1020 doi:10.1002/jha2.464.

    PMID: 36051078
  15. 15

    Approach to hyperleukocytosis and leukostasis-inpatient management strategies.

    Baral MR, Bhandari S

    Journal of hospital medicine 2026; (21(5)):534-538 doi:10.1002/jhm.70199.

    PMID: 41058090
  16. 16

    Coexistence of Chronic Myelomonocytic Leukemia and Ulcerative Colitis With Rapid Progression to Acute Myelomonocytic Leukemia: A Case Report.

    Pelkey LJ, Graham DM, Zakem MH, Muza-Moons MM

    Cureus 2022; (14(2)):e22422 doi:10.7759/cureus.22422.

    PMID: 35228982
  17. 17

    Post-operative hyperleukocytosis and leukostasis as the initial presentation of chronic myelomonocytic leukemia: A case report and review of literature.

    Gaur S, Philipovskiy A, Orazi A

    Leukemia research reports 2021; (16()):100283 doi:10.1016/j.lrr.2021.100283.

    PMID: 34934616
  18. 18

    Outcomes of Patients With Newly Diagnosed AML and Hyperleukocytosis.

    Haddad FG, Sasaki K, Senapati J, et al.

    JCO oncology practice 2024; (20(12)):1637-1644 doi:10.1200/OP.24.00027.

    PMID: 39013130
  19. 19

    The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score-matched study.

    Choi MH, Choe YH, Park Y, et al.

    Transfusion 2018; (58(1)):208-216 doi:10.1111/trf.14329.

    PMID: 28960357
  20. 20

    Chronic Myelomonocytic Leukemia (CMML) as a Rare Cause of Spontaneous Atraumatic Splenic Rupture in a 65-Year-Old Male.

    Sabbagh MN, Hoerdeman B, Hooshyar R, Ejeh I

    Cureus 2025; (17(3)):e80357 doi:10.7759/cureus.80357.

    PMID: 40206915
  21. 21

    Rare cases of atraumatic splenic rupture managed conservatively in patients with myeloid neoplasms: a report of two cases and literature review.

    Chen M, Jiang M, Zhang W, et al.

    Chinese clinical oncology 2025; (14(2)):21 doi:10.21037/cco-24-122.

    PMID: 40337877
  22. 22

    Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: Expanding the spectrum of skin lesions in chronic myelomonocytic leukemia.

    Loghavi S, Curry JL, Garcia-Manero G, et al.

    Journal of cutaneous pathology 2017; (44(12)):1075-1079 doi:10.1111/cup.13039.

    PMID: 28885734
  23. 23

    Leukaemia cutis as a specific skin involvement in chronic myelomonocytic leukaemia and review of the literature: Acknowledgments.

    Qiao Y, Jian J, Deng L, et al.

    Translational cancer research 2020; (9(8)):4988-4998 doi:10.21037/tcr-19-2882.

    PMID: 35117861
  24. 24

    Atypical cutaneous histiocytic eruption in a patient with chronic myelomonocytic leukemia: A case report.

    Li JJ, Talam S, Star P, Getta B

    Journal of cutaneous pathology 2021; (48(5)):680-688 doi:10.1111/cup.13957.

    PMID: 33416192

This page is for informational purposes only and does not constitute medical advice. Contact your hematology team promptly about new, severe, or worsening CMML symptoms.